TY - JOUR
T1 - Cardiac Events After Mechanical Thrombectomy in Acute Ischemic Stroke
T2 - A Nation-Wide Cohort Study
AU - Laugesen, Nicolaj Grønbæk
AU - Hedegaard, Jakob Nebeling
AU - Gaist, David
AU - Simonsen, Claus Ziegler
AU - Modrau, Boris
AU - Hansen, Klaus
AU - Johnsen, Søren Paaske
AU - Truelsen, Thomas
PY - 2025
Y1 - 2025
N2 - IntroductionMechanical thrombectomy (MT) markedly improves the outcome in patients with large vessel occlusion stroke. Given the cardiovascular risk profile of these patients, we wanted to investigate their post-MT risk of cardiac events compared to other patients with acute ischemic stroke (AIS).MethodsAll hospitalizations for AIS in Denmark from 2014 to 2021 were included in this registry-based cohort study. Patients were categorized by reperfusion treatment: MT with or without intravenous thrombolysis (IVT), IVT alone, or no reperfusion treatment (NRT). Cardiac events included ischemic heart disease, heart failure, or cardiac death within 6 months of AIS. Pair-wise group comparisons were performed after inverse probability treatment weighting (IPTW).ResultsAmong 76,092 AIS patients, 4.4% received MT, 15.2% received IVT alone, and 80.4% received NRT. In the MT group, 9.6% of patients experienced cardiac events. After IPTW, MT patients had the highest risk of cardiac events compared to IVT (absolute risk difference [ARD] 4.6%, cause-specific hazard rate ratio [HRR] 1.42 [95% CI: 1.27-1.60]) and NRT (ARD 4.6%, HRR 1.35 [95% CI: 1.22-1.49]). Pre-existing cardiac disease was similar across groups (9.2%-11.8%) and after exclusion of patients with prior cardiac disease, the HRR of cardiac events remained consistent with the primary analysis (MT vs. IVT: HRR 1.48 [95% CI: 1.31-1.68]; MT vs. NRT: 1.39 [95% CI: 1.24-155]).Conclusion10% of patients with AIS undergoing MT experienced cardiac events within 6 months compared to 5% of other AIS patients. This study identified an unrecognized burden of cardiac disease in this group of AIS patients treated with MT.
AB - IntroductionMechanical thrombectomy (MT) markedly improves the outcome in patients with large vessel occlusion stroke. Given the cardiovascular risk profile of these patients, we wanted to investigate their post-MT risk of cardiac events compared to other patients with acute ischemic stroke (AIS).MethodsAll hospitalizations for AIS in Denmark from 2014 to 2021 were included in this registry-based cohort study. Patients were categorized by reperfusion treatment: MT with or without intravenous thrombolysis (IVT), IVT alone, or no reperfusion treatment (NRT). Cardiac events included ischemic heart disease, heart failure, or cardiac death within 6 months of AIS. Pair-wise group comparisons were performed after inverse probability treatment weighting (IPTW).ResultsAmong 76,092 AIS patients, 4.4% received MT, 15.2% received IVT alone, and 80.4% received NRT. In the MT group, 9.6% of patients experienced cardiac events. After IPTW, MT patients had the highest risk of cardiac events compared to IVT (absolute risk difference [ARD] 4.6%, cause-specific hazard rate ratio [HRR] 1.42 [95% CI: 1.27-1.60]) and NRT (ARD 4.6%, HRR 1.35 [95% CI: 1.22-1.49]). Pre-existing cardiac disease was similar across groups (9.2%-11.8%) and after exclusion of patients with prior cardiac disease, the HRR of cardiac events remained consistent with the primary analysis (MT vs. IVT: HRR 1.48 [95% CI: 1.31-1.68]; MT vs. NRT: 1.39 [95% CI: 1.24-155]).Conclusion10% of patients with AIS undergoing MT experienced cardiac events within 6 months compared to 5% of other AIS patients. This study identified an unrecognized burden of cardiac disease in this group of AIS patients treated with MT.
KW - Ais
KW - Cardiac events
KW - Cerebrovascular disorders
KW - Heart disease after stroke
KW - Reperfusion treatment
KW - Stroke
KW - Stroke-heart syndrome
KW - Thrombectomy
U2 - 10.1111/ene.70223
DO - 10.1111/ene.70223
M3 - Journal article
C2 - 40432265
SN - 1351-5101
VL - 32
JO - European Journal of Neurology
JF - European Journal of Neurology
IS - 6
M1 - e70223
ER -